Resideo Technologies, Inc. REZI
19.24 USD -0.01 (-0.05%)
At closeNov 3, 2026, 6:40 PM EST
19.25 +0.01 +0.05%
After hours · Nov 3, 6:40 PM ET
19.09 Day range 19.47
15.90 52-week range 29.89
- YTD
- -21.28%
- 1 year
- -35.35%
Analyst view
Price target (mean) 29.83 +55.1% upside
Now 19.24
- Target (low)
- 20.00
- Target (mean)
- 29.83
- Target (high)
- 45.00
Ratings (0m) 6 5 buy · 1 hold · 0 sell
- Strong buy2
- Buy3
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 5
- 2 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.40333 | 0.31 – 0.46 | 0.89 | -54.7% | 714.00M | -61.7% | 3 |
| Next quarter | 0.455 | 0.45 – 0.46 | 0.50 | -9.0% | 729.33M | -61.5% | 2 |
| Current year | 2.00 | 1.34 – 2.37 | 2.68 | -25.4% | 4.14B | -44.6% | 3 |
| Next year | 2.06 | 2.05 – 2.06 | 2.00 | +2.8% | 3.02B | -27.1% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 19, 2026 | Citizens | Initiated | — | Market Outperform |
| Sep 28, 2026 | Evercore ISI Group | Initiated | — | Outperform |
| Jul 13, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Feb 25, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Sep 19, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 12, 2025 | Morgan Stanley | Upgrade | Equal-Weight | Overweight |
| Jun 3, 2025 | JP Morgan | Maintained | Neutral | Neutral |
| May 8, 2025 | JP Morgan | Maintained | Neutral | Neutral |
| Apr 22, 2025 | JP Morgan | Downgrade | Overweight | Neutral |
| Aug 4, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| May 4, 2023 | Morgan Stanley | Maintained | — | Equal-Weight |
| Jan 18, 2023 | Morgan Stanley | Maintained | — | Equal-Weight |
| Nov 2, 2022 | Imperial Capital | Downgrade | Outperform | In-Line |
| Oct 17, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| May 4, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| Feb 16, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| Oct 6, 2021 | Morgan Stanley | Maintained | — | Equal-Weight |
| Sep 21, 2021 | Morgan Stanley | Maintained | — | Equal-Weight |
| Mar 17, 2021 | Morgan Stanley | Initiated | — | Equal-Weight |
| Mar 11, 2021 | Roth Capital | Downgrade | Buy | Neutral |
| Mar 3, 2021 | William Blair | Initiated | — | Market Perform |
| Dec 21, 2020 | JP Morgan | Initiated | — | Overweight |
| Jun 8, 2020 | Imperial Capital | Maintained | — | In-Line |
| Apr 28, 2020 | Imperial Capital | Downgrade | Outperform | In-Line |
| Feb 28, 2020 | Imperial Capital | Upgrade | In-Line | Outperform |
| Jan 7, 2020 | B of A Securities | Upgrade | Neutral | Buy |
| Nov 8, 2019 | Imperial Capital | Downgrade | Outperform | In-Line |
| Oct 24, 2019 | Imperial Capital | Maintained | — | Outperform |
| Oct 23, 2019 | B of A Securities | Downgrade | Buy | Neutral |
| Oct 23, 2019 | Oppenheimer | Downgrade | Outperform | Perform |